Fucosidase Deficiency Diseases

Untitled Document

Art dictionary
Financial dictionary
Hollywood dictionary
Insurance dictionary
Literature dictionary
Real Estate dictionary
Tourism dictionary

Fucosidase Deficiency Diseases

Fucosidase Deficiency Diseases

An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

RELATED TERMS
--------------------------------------

Autosomal
"Pertaining to a chromosome that is not a sex chromosome; relating to any one of the chromosomes save the sex chromosomes. People normally have 22 pairs of autosomes (44 autosomes) in each cell together with two sex chromosomes (X and Y in the male and XX in the female). "

Disease
Illness or sickness often characterized by typical patient problems (symptoms) and physical findings (signs). Disruption sequence: The events that occur when a fetus that is developing normally is subjected to a destructive agent such as the rubella (German measles) virus.

GLYCOPROTEINS
Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.

MUSCLE
Tissue made up of bundles of long, slender cells that contract when stimulated.

SPASTICITY
Involuntary muscle tightness and stiffness that occurs in about two-thirds of people with cerebral palsy and in many who suffer severe head injuries. The medical definition of dystonia is a velocity-dependent, increased resistance to passive muscle stretch. In other words, when a muscle affected by spasticity is stretched by someone else, it is harder to move the muscle than normal, and the faster one pushes, the harder the muscle is to move.

Retardation
Delay or halt of any process such as mental or physical development.

Death
1. The end of life. The cessation of life. (These common definitions of death ultimately depend upon the definition of life, upon which there is no consensus.) 2. The permanent cessation of all vital bodily functions. (This definition depends upon the definition of "vital bodily functions.") See: Vital bodily functions. 3. The common law standard for determining death is the cessation of all vital functions, traditionally demonstrated by "an absence of spontaneous respiratory and cardiac functions." 4. The uniform determination of death.

Fucosidosis
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Neurology
The branch of medicine that pertains to the nervous system.

SIMILAR TERMS
--------------------------------------

Fucose, GDP
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fucose, Guanosine Diphosphate
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fucosidase
An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause FUCOSIDOSIS. EC 3.2.1.51.

Fucosidase Deficiency Disease
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis Type I
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis Type II
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis, Infantile
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosidosis, Juvenile
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucosyl Galactose Acetylgalactosaminyltransferase
An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.

Fucosyl Galactose alpha N Acetylgalactosaminyltransferase
An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.

Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase
An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.

Fucosyl SSEA 1
Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.

Fucosyl SSEA-1
Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.

Fucosyltransferases
Enzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89.

PREVIOUS AND NEXT TERMS
--------------------------------------

FSH Receptors
Cell surface proteins that bind FOLLICLE STIMULATING HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells.

FSH Receptor
Cell surface proteins that bind FOLLICLE STIMULATING HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells.

FSH alpha
A non-covalently bound subunit of the glycoprotein hormones TSH; FOLLICLE STIMULATING HORMONE; LH; and HCG which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uremia and malignant tumors. The alpha subunit may be involved directly in recognition of certain receptors.

FSH
A gonadotropic hormone found in the anterior pituitary gland (PITUITARY GLAND, ANTERIOR) of mammals. It stimulates ovarian granulosa cells and testicular Sertoli cells, induces maturation of Graafian follicles in the ovary, and promotes the development of the germinal cells in the testis.

Frustration
The motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated.

Fucosidase Deficiency Diseases

Fucosidase Deficiency Disease
An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS, GLYCOPROTEINS, and mucopolysaccharides (GLYCOSAMINOGLYCANS) in lysosomes. The infantile form (type I) features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis (type II) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. (From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38(1):111-31)

Fucose, GDP
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fucose, Guanosine Diphosphate
A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.

Fuchsin
Any dye or mixture of dyes made from rosaniline, a red triphenylmethane aniline derivative.

Fuchsins
Any dye or mixture of dyes made from rosaniline, a red triphenylmethane aniline derivative.

We thank you for using the Health Dictionary to search for Fucosidase Deficiency Diseases. If you have a better definition for Fucosidase Deficiency Diseases than the one presented here, please let us know by making use of the suggest a term option. This definition of Fucosidase Deficiency Diseases may be disputed by other professionals. Our attempt is to provide easy definitions on Fucosidase Deficiency Diseases and any other medical topic for the public at large.

This dictionary contains 59020 terms.

fucosidasedeficiencydiseases / ucosidase deficiency diseases / fcosidase deficiency diseases / fuosidase deficiency diseases / fucsidase deficiency diseases / fucoidase deficiency diseases / fucosdase deficiency diseases / fucosiase deficiency diseases / fucosidse deficiency diseases / fucosidae deficiency diseases / fucosidas deficiency diseases / fucosidasedeficiency diseases / fucosidase eficiency diseases / fucosidase dficiency diseases / fucosidase deiciency diseases / fucosidase defciency diseases / fucosidase defiiency diseases / fucosidase deficency diseases / fucosidase deficincy diseases / fucosidase deficiecy diseases / fucosidase deficieny diseases / fucosidase deficienc diseases / fucosidase deficiencydiseases / fucosidase deficiency iseases / fucosidase deficiency dseases / fucosidase deficiency dieases / fucosidase deficiency disases / fucosidase deficiency diseses / fucosidase deficiency diseaes / fucosidase deficiency diseass / fucosidase deficiency disease / ffucosidase deficiency diseases / fuucosidase deficiency diseases / fuccosidase deficiency diseases / fucoosidase deficiency diseases / fucossidase deficiency diseases / fucosiidase deficiency diseases / fucosiddase deficiency diseases / fucosidaase deficiency diseases / fucosidasse deficiency diseases / fucosidasee deficiency diseases / fucosidase deficiency diseases / fucosidase ddeficiency diseases / fucosidase deeficiency diseases / fucosidase defficiency diseases / fucosidase defiiciency diseases / fucosidase deficciency diseases / fucosidase deficiiency diseases / fucosidase deficieency diseases / fucosidase deficienncy diseases / fucosidase deficienccy diseases / fucosidase deficiencyy diseases / fucosidase deficiency diseases / fucosidase deficiency ddiseases / fucosidase deficiency diiseases / fucosidase deficiency disseases / fucosidase deficiency diseeases / fucosidase deficiency diseaases / fucosidase deficiency diseasses / fucosidase deficiency diseasees / fucosidase deficiency diseasess / rucosidase deficiency diseases / tucosidase deficiency diseases / gucosidase deficiency diseases / bucosidase deficiency diseases / vucosidase deficiency diseases / cucosidase deficiency diseases / ducosidase deficiency diseases / eucosidase deficiency diseases / f7cosidase deficiency diseases / f8cosidase deficiency diseases / ficosidase deficiency diseases / fkcosidase deficiency diseases / fjcosidase deficiency diseases / fhcosidase deficiency diseases / fycosidase deficiency diseases / f6cosidase deficiency diseases / fuxosidase deficiency diseases / fusosidase deficiency diseases / fudosidase deficiency diseases / fufosidase deficiency diseases / fuvosidase deficiency diseases / fu osidase deficiency diseases / fuc9sidase deficiency diseases / fuc0sidase deficiency diseases / fucpsidase deficiency diseases / fuclsidase deficiency diseases / fucksidase deficiency diseases / fucisidase deficiency diseases / fuc8sidase deficiency diseases / fucowidase deficiency diseases / fucoeidase deficiency diseases / fucodidase deficiency diseases / fucoxidase deficiency diseases / fucozidase deficiency diseases / fucoaidase deficiency diseases / fucoqidase deficiency diseases / fucosdase deficiency diseases / fucosiease deficiency diseases / fucosirase deficiency diseases / fucosifase deficiency diseases / fucosivase deficiency diseases / fucosicase deficiency diseases / fucosixase deficiency diseases / fucosisase deficiency diseases / fucosiwase deficiency diseases / fucosidqse deficiency diseases / fucosidwse deficiency diseases / fucosidsse deficiency diseases / fucosidxse deficiency diseases / fucosidzse deficiency diseases / fucosidawe deficiency diseases / fucosidaee deficiency diseases / fucosidade deficiency diseases / fucosidaxe deficiency diseases / fucosidaze deficiency diseases / fucosidaae deficiency diseases / fucosidaqe deficiency diseases / fucosidas3 deficiency diseases / fucosidas4 deficiency diseases / fucosidasr deficiency diseases / fucosidasf deficiency diseases / fucosidasd deficiency diseases / fucosidass deficiency diseases / fucosidasw deficiency diseases / fucosidase eeficiency diseases / fucosidase reficiency diseases / fucosidase feficiency diseases / fucosidase veficiency diseases / fucosidase ceficiency diseases / fucosidase xeficiency diseases / fucosidase seficiency diseases / fucosidase weficiency diseases / fucosidase d3ficiency diseases / fucosidase d4ficiency diseases / fucosidase drficiency diseases / fucosidase dfficiency diseases / fucosidase ddficiency diseases / fucosidase dsficiency diseases / fucosidase dwficiency diseases / fucosidase dericiency diseases / fucosidase deticiency diseases / fucosidase degiciency diseases / fucosidase debiciency diseases / fucosidase deviciency diseases / fucosidase deciciency diseases / fucosidase dediciency diseases / fucosidase deeiciency diseases / fucosidase defciency diseases / fucosidase defixiency diseases / fucosidase defisiency diseases / fucosidase defidiency diseases / fucosidase defifiency diseases / fucosidase defiviency diseases / fucosidase defi iency diseases / fucosidase deficency diseases / fucosidase defici3ncy diseases / fucosidase defici4ncy diseases / fucosidase deficirncy diseases / fucosidase deficifncy diseases / fucosidase deficidncy diseases / fucosidase deficisncy diseases / fucosidase deficiwncy diseases / fucosidase deficiebcy diseases / fucosidase deficiehcy diseases / fucosidase deficiejcy diseases / fucosidase deficiemcy diseases / fucosidase deficie cy diseases / fucosidase deficienxy diseases / fucosidase deficiensy diseases / fucosidase deficiendy diseases / fucosidase deficienfy diseases / fucosidase deficienvy diseases / fucosidase deficien y diseases / fucosidase deficienc6 diseases / fucosidase deficienc7 diseases / fucosidase deficiencu diseases / fucosidase deficiencj diseases / fucosidase deficiench diseases / fucosidase deficiencg diseases / fucosidase deficienct diseases / fucosidase deficienc5 diseases / fucosidase deficiency eiseases / fucosidase deficiency riseases / fucosidase deficiency fiseases / fucosidase deficiency viseases / fucosidase deficiency ciseases / fucosidase deficiency xiseases / fucosidase deficiency siseases / fucosidase deficiency wiseases / fucosidase deficiency dseases / fucosidase deficiency diweases / fucosidase deficiency dieeases / fucosidase deficiency dideases / fucosidase deficiency dixeases / fucosidase deficiency dizeases / fucosidase deficiency diaeases / fucosidase deficiency diqeases / fucosidase deficiency dis3ases / fucosidase deficiency dis4ases / fucosidase deficiency disrases / fucosidase deficiency disfases / fucosidase deficiency disdases / fucosidase deficiency dissases / fucosidase deficiency diswases / fucosidase deficiency diseqses / fucosidase deficiency disewses / fucosidase deficiency disesses / fucosidase deficiency disexses / fucosidase deficiency disezses / fucosidase deficiency diseawes / fucosidase deficiency diseaees / fucosidase deficiency diseades / fucosidase deficiency diseaxes / fucosidase deficiency diseazes / fucosidase deficiency diseaaes / fucosidase deficiency diseaqes / fucosidase deficiency diseas3s / fucosidase deficiency diseas4s / fucosidase deficiency diseasrs / fucosidase deficiency diseasfs / fucosidase deficiency diseasds / fucosidase deficiency diseasss / fucosidase deficiency diseasws / fucosidase deficiency diseasew / fucosidase deficiency diseasee / fucosidase deficiency diseased / fucosidase deficiency diseasex / fucosidase deficiency diseasez / fucosidase deficiency diseasea / fucosidase deficiency diseaseq /